SUPPLEMENT NO. 2 DATED DECEMBER 2, 1996
                     TO PROSPECTUS DATED SEPTEMBER 16, 1996
                         RELATING TO 482,377 SHARES OF
                         RENAL TREATMENT CENTERS, INC.
                          COMMON STOCK, $.01 PAR VALUE


     All capitalized terms used but not defined herein shall have the meanings
prescribed in the Prospectus dated September 16, 1996, as supplemented by
Supplement No. 1 dated November 4, 1996, forming a part of Form S-3 Registration
Statement No. 333-10841.

     Scott E. Dean, M.D., a Selling Stockholder, has transferred 700 of the
29,685 shares of Common Stock beneficially owned by him and covered by the
Prospectus to a trust created for the benefit of his minor children, the Dean
Minors Trust of 1996 (the "Dean Trust").  Frank B. Martin, an employee of the
Company, is the trustee of the Dean Trust, and has sole voting and investment
power with respect to these 700 shares of Common Stock.  Dr. Dean retains sole
voting and investment power with respect to the remaining 28,985 shares of
Common Stock.  The definition of "Selling Stockholders" in the Prospectus is
amended hereby to include the Dean Trust.  With the exception of Mr. Martin's
employment by the Company, neither the Dean Trust, nor any trustee or
beneficiary thereof, is now, or ever has been, an officer, director or employee
of the Company, nor does any such person have any other relationship with the
Company.